TransMedics to Present at the Canaccord Genuity 46th Annual Growth Conference

TransMedics (Nasdaq: TMDX) announced it will participate in the Canaccord Genuity 46th Annual Growth Conference in Boston on Tuesday, August 11, 2026.

Rhea-AI Summary

TransMedics (Nasdaq: TMDX) announced it will participate in the Canaccord Genuity 46th Annual Growth Conference in Boston on Tuesday, August 11, 2026. The TransMedics management team is scheduled to present at 2:00 p.m. ET / 1:00 p.m. CT. A live and archived webcast of the fireside chat, along with the company’s standard investor presentation, will be accessible via the Investors section of the TransMedics website.

Argus Jul 29 session

+2.24% close to close Open Argus

Details

News Market Reaction – TMDX

In the Jul 29 session, TMDX gained 2.24%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

The 2026-05-19 conference-presentation notice was followed by a 2.83% 24-hour reaction, providing a ...

Analysis

The 2026-05-19 conference-presentation notice was followed by a 2.83% 24-hour reaction, providing a comparable reference for this event. The platform also records Net Selling and moderate short positioning as risks to monitor.

Key Figures

Announcement date: July 28, 2026 Conference edition: 46th annual Conference date: August 11, 2026 +1 more

Announcement date

July 28, 2026

Conference participation announcement

Conference edition

46th annual

Canaccord Genuity Growth Conference

Conference date

August 11, 2026

Boston event

Presentation time

2:00 p.m. ET / 1:00 p.m. CT

Management fireside chat

Historical Context

5 past events · Latest: Jul 21

5 events

1. Jul 21

   earnings date notice

   24h Move

   -4.2%

   Announced Q2 2026 results date; shares fell 4.16% over the following 24 hours.

2. Jul 06

   strategic investment

   24h Move

   +3.4%

   Completed PAD Aviation investment to support European transplant logistics expansion.

3. May 21

   inducement equity grants

   24h Move

   +0.1%

   Granted equity awards to 14 new employees under Nasdaq listing rules.

4. May 19

   growth conference presentation

   24h Move

   +2.8%

   Announced William Blair conference participation; shares rose 2.83% over 24 hours.

5. May 05

   first-quarter earnings

   24h Move

   -23.2%

   Reported $173.9M revenue and reiterated guidance; shares fell 23.19% over 24 hours.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

ANDOVER, Mass., July 28, 2026 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced the company will be participating in the Canaccord Genuity 46^th Annual Growth Conference in Boston on Tuesday, August 11, 2026. The TransMedics management team will present beginning at 2:00 p.m. ET/ 1:00 p.m. CT

A live and archived webcast of the fireside chat will be available on the "Investors" section of the TransMedics website at https://investors.transmedics.com/. The Company's standard investor presentation is also available through this link.

About TransMedics Group, Inc.
TransMedics is the world's leader in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Headquartered in Andover, Massachusetts, the company was founded to address the unmet need for more and better organs for transplantation and has developed technologies to preserve organ quality, assess organ viability prior to transplant, and potentially increase the utilization of donor organs for the treatment of end-stage heart, lung, and liver failure.

Investor Contact:
Brian Johnston
Hannah Jeffrey
332-895-3222
Investors@transmedics.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/transmedics-to-present-at-the-canaccord-genuity-46th-annual-growth-conference-302836981.html

SOURCE TransMedics Group, Inc.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will TransMedics (TMDX) present at the Canaccord Genuity 46th Annual Growth Conference in 2026?

TransMedics will present on Tuesday, August 11, 2026, at 2:00 p.m. ET / 1:00 p.m. CT. According to TransMedics, this presentation is part of the Canaccord Genuity 46th Annual Growth Conference in Boston.

How can investors access the TransMedics (TMDX) webcast from the Canaccord Genuity 46th Annual Growth Conference?

Investors can access a live and archived webcast via the TransMedics Investors website section. According to TransMedics, the fireside chat stream and replay will be available through https://investors.transmedics.com/.

Will a replay of the TransMedics (TMDX) fireside chat at the Canaccord Genuity conference be available?

Yes, an archived webcast of the fireside chat will be available after the event. According to TransMedics, both live and archived versions can be accessed through the company’s Investors section online.

Where is the Canaccord Genuity 46th Annual Growth Conference featuring TransMedics (TMDX) being held?

The conference featuring TransMedics is being held in Boston in 2026. According to TransMedics, its management team will participate and present there on August 11, 2026.

Where can I find the standard investor presentation for TransMedics (TMDX)?

TransMedics’ standard investor presentation is available through the company’s Investors section online. According to TransMedics, it can be accessed at https://investors.transmedics.com/ alongside the conference webcast link.